Psychoactive substances are regulated in New Zealand by the Psychoactive Substances Act 2013. The aim of the Act is to protect the health of, and minimise harm to, individuals who use psychoactive substances. The Psychoactive Substances Regulatory Authority administers the Act.
Following a number of deaths and hospitalisations around the country that are thought to be linked to the use of synthetic cannabinoids, the Ministry of Health is supporting an initiative by the Institute of Environmental Science and Research (ESR), the USED programme. ESR has secured funding to allow the programme to run until June 2019.
Psychoactive Substances Act 2013
The Act aims to regulate the availability of psychoactive substances in New Zealand to protect the health of, and minimise harm to, individuals who use psychoactive substances. Read more
How to get a product approved
Information for applicants submitting a product approval application. Read more
- The Code of Manufacturing Practice outlines the quality control requirements for manufacturers of psychoactive substances.
- Register of Product Approvals - Note: There are no approved products and no applications for a product have been received.
How to get a licence
Find out about the cost of and how to apply for a licence to import, research, manufacture, wholesale, retail, sell unapproved substances. Read more
Information for healthcare professionals
Information about the Unidentified Substance in Emergency Departments (USED) Programme, clinical advice, guidance and forms, and clinical coding for synthetic cannabis. Read more
Psychoactive Substances Expert Advisory Committee
The Psychoactive Substances Expert Advisory Committee provides technical advice to the Authority. Read more.
The Psychoactive Substances Appeals Committee
The Psychoactive Substances Appeals Committee (PSAC) hears appeals against decisions made by the Psychoactive Substances Regulatory Authority. Read more